Search results for "Highlights"
Model that blends machine learning, traditional risk score may improve cirrhosis prediction
Using clinical variables identified from simple machine learning in a cirrhosis mortality model produced a new score that was more transparent than a commonly used version of the Model for End-Stage Liver Disease, a study found.
https://gastroenterology.acponline.org/archives/2020/11/20/3.htm
20 Nov 2020
Colonoscopy surveillance every 3 years may be sufficient after polypectomy
A multicenter randomized trial in Japan found that a single surveillance colonoscopy three years postpolypectomy and two surveillance colonoscopies at one and three years were similarly accurate for detecting clinically important neoplastic lesions.
https://gastroenterology.acponline.org/archives/2020/11/20/2.htm
20 Nov 2020
Semaglutide showed some benefit in patients with NASH, liver fibrosis
Significantly more patients taking the glucagon-like peptide-1 receptor agonist had resolution of their nonalcoholic steatohepatitis (NASH) than those taking placebo, but rates of liver fibrosis improvement were similar between groups, an industry-funded trial found.
https://gastroenterology.acponline.org/archives/2020/11/20/1.htm
20 Nov 2020
Practice guidance addresses vascular liver disorders, portal vein thrombosis, procedural bleeding
Among other statements, the American Association for the Study of Liver Diseases said that modifiable risk factors for bleeding, such as use of antithrombotic drugs, should be identified and corrected before procedures in patients with cirrhosis.
https://gastroenterology.acponline.org/archives/2020/12/18/2.htm
18 Dec 2020
Three rounds of FIT had higher CRC detection rates than one sigmoidoscopy, study finds
Participation was higher and more colorectal cancer (CRC) and advanced adenomas were detected with repeated fecal immunochemical testing (FIT) compared to sigmoidoscopy, although the risks of perforation and bleeding were comparable.
https://gastroenterology.acponline.org/archives/2020/12/18/3.htm
18 Dec 2020
Cirrhosis puts COVID-19 patients at higher risk of hospitalization, death
An analysis of U.S. veterans with and without cirrhosis who were tested for SARS-CoV-2 this spring found a 30-day mortality rate of 17.1% in patients with both conditions, compared to 2.3% in those with neither COVID-19 nor cirrhosis.
https://gastroenterology.acponline.org/archives/2020/12/18/1.htm
18 Dec 2020
More frequent bowel movements may be associated with diverticulitis risk
An analysis of participants in the Nurses' Health Study and the Health Professionals Follow-up Study found that more frequent bowel movements appear to be a risk factor for subsequent diverticulitis in both men and women.
https://gastroenterology.acponline.org/archives/2021/01/22/2.htm
22 Jan 2021
Prevalence of liver fibrosis in diabetes suggests need for earlier intervention, study finds
The prevalence of any suspected liver fibrosis in patients with diabetes was 21% in a recent study, leading the authors to call for more aggressive screening in patients with obesity and diabetes.
https://gastroenterology.acponline.org/archives/2021/01/22/3.htm
22 Jan 2021
Liver function tests at admission could help predict mortality from COVID-19
Elevations in aspartate aminotransferase and direct bilirubin levels were significantly more common among patients in China who died of COVID-19 than those who survived to hospital discharge, a retrospective study found.
https://gastroenterology.acponline.org/archives/2021/01/22/1.htm
22 Jan 2021
Half of overweight, obese adults may have fatty liver disease
The global prevalence of metabolic dysfunction-associated fatty liver disease, a newly proposed term for nonalcoholic fatty liver disease, is “astonishingly high,” the authors of a recent meta-analysis found.
https://gastroenterology.acponline.org/archives/2021/02/26/3.htm
26 Feb 2021